Safety of pioglitazone during and after radiation therapy in patients with brain tumors: a phase I clinical trial

ConclusionPioglitazone was well tolerated by brain tumor patients undergoing RT. 45  mg is a safe dose to use in future efficacy trials.
Source: Journal of Cancer Research and Clinical Oncology - Category: Cancer & Oncology Source Type: research